NeuroNexus develops and commercializes high-value neural interface technology, components and systems for neuroscience and clinical markets.
NeuroNexus' proprietary microelectronic, fluidic, and optical technology is used to "map" brain function, detect neural activity, and stimulate or modulate neural circuits when brain function is impaired.
NeuroNexus is a leader in transforming ideas to technologies and technologies to innovative products by working at the leading-edge of science, technology, and clinical applications.
NeuroNexus is located in Ann Arbor, Michigan, USA.